Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
50.75
+4.17 (8.95%)
At close: Feb 6, 2026, 4:00 PM EST
51.74
+0.99 (1.95%)
After-hours: Feb 6, 2026, 4:03 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Complement Therapeutics
6.24M
Complement Therapeutics Growth
120.63%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
6.24M
United States Growth
120.63%